{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T13:35:47Z","timestamp":1767792947913,"version":"3.49.0"},"reference-count":37,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"unspecified","delay-in-days":17,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"SVNPAR Sociedad Vasco-Navarra de Patologia Respiratoria","award":["01-2024"],"award-info":[{"award-number":["01-2024"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,10,25]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>An increase in airway isolates of non-tuberculous mycobacteria (NTM) has been observed, particularly in patients with previous lung damage. Inhaled corticosteroids may increase the risk of NTM lung disease. NTM isolation is of therapeutic importance, especially when macrolides are used. There are few data on the actual prevalence of NTM isolation in patients with chronic obstructive pulmonary disease (COPD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the prevalence of NTM isolation and NTM pulmonary disease according to the ATS\/ERS\/IDSA 2020 criteria in patients with high-risk COPD. As a secondary objective, we sought to identify risk factors for NTM isolation and developing NTM pulmonary disease in patients with COPD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Prospective multicentre observational study based on the collection of three sputum samples in a year, for standard, mycobacteria and fungi cultures, in patients with high-risk COPD (postbronchodilator forced expiratory volume in 1 s&lt;50% and\/or \u22652 exacerbations in the previous year), with a 12-month follow-up. Patients with at least two good-quality samples were included.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>305 patients were initially selected, of which only 258 had at least two valid samples. NTM was isolated in 15% of patients (n=39), though only 8 (3%) met the ATS 2020 criteria for NTM disease. The most commonly isolated species was mycobacterium avium complex (MAC). Multivariate analysis identified the following risk factors for NTM isolation: low body weight, alpha-1 antitrypsin (AAT) deficiency, inhaled corticosteroids and cancer. NTM disease was only associated with body mass index &lt;21.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>NTM isolation is more common than expected in patients with COPD and may have implications for treatment. It is associated with low body weight, AAT deficiency, inhaled corticosteroid use and cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-003691","type":"journal-article","created":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T11:15:11Z","timestamp":1766488511000},"page":"e003691","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Non-tuberculous mycobacteria (NTM) and COPD: a multicentre prospective study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7255-9290","authenticated-orcid":false,"given":"Eva","family":"Tabernero","sequence":"first","affiliation":[{"name":"Cruces University Hospital, Barakaldo, Spain"},{"name":"Instituto de Investigaci\u00f3n Sanitaria Biobizkaia, Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaia","family":"Aramburu","sequence":"additional","affiliation":[{"name":"Pneumology Service, Galdakao-Usansolo Hospital, Galdakao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Sanchez","sequence":"additional","affiliation":[{"name":"Basurto University Hospital, Bilbao, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borja","family":"Santos","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Sanitaria Biocruces Biobizkaia, Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Ortiz","sequence":"additional","affiliation":[{"name":"Pneumology Service, Cruces University Hospital, Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Lopez de Calle","sequence":"additional","affiliation":[{"name":"Pneumology Service, Cruces University Hospital, Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larraitz","family":"Garcia","sequence":"additional","affiliation":[{"name":"Cruces University Hospital, Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Urra","sequence":"additional","affiliation":[{"name":"Microbiology Service, Cruces University Hospital, Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Sobradillo","sequence":"additional","affiliation":[{"name":"Cruces University Hospital, Barakaldo, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,12,21]]},"reference":[{"key":"2026010701521256000_12.1.e003691.1","unstructured":"GOLD . Global strategy for prevention diagnosis and management of COPD. 2025. Available: https:\/\/goldcopd.org\/2025-gold-report\/"},{"key":"2026010701521256000_12.1.e003691.2","doi-asserted-by":"crossref","first-page":"T69","DOI":"10.1016\/j.arbres.2021.03.026","article-title":"[Translated article] Spanish COPD guidelines (GesEPOC) 2021: Updated pharmacological treatment of stable COPD","volume":"58","author":"Miravitlles","year":"2022","journal-title":"Archivos de Bronconeumolog\u00eda"},{"key":"2026010701521256000_12.1.e003691.3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.2147\/COPD.S369118","article-title":"Pulmonologists\u2019 Opinion on the Use of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Patients in Spain: A Cross-Sectional Survey","volume":"Volume 17","author":"Miravitlles","year":"2022","journal-title":"COPD"},{"key":"2026010701521256000_12.1.e003691.4","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.201908-1550OC","article-title":"Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis","volume":"201","author":"Martinez-Garcia","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"2026010701521256000_12.1.e003691.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.10.013"},{"key":"2026010701521256000_12.1.e003691.6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.chest.2023.06.014","article-title":"Risk Factors for Nontuberculous Mycobacterial Pulmonary Disease: A Systematic Literature Review and Meta-Analysis","volume":"164","author":"Loebinger","year":"2023","journal-title":"Chest"},{"key":"2026010701521256000_12.1.e003691.7","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-018-3402-8"},{"key":"2026010701521256000_12.1.e003691.8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197976","article-title":"Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration","volume":"13","author":"Jones","year":"2018","journal-title":"PLoS ONE"},{"key":"2026010701521256000_12.1.e003691.9","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2024.100353","article-title":"Nontuberculous Mycobacteria Isolates in Respiratory Samples and Mycobacterial Pulmonary Disease in an Area of Northern Spain","volume":"6","author":"Ugedo","year":"2024","journal-title":"Open Respir Arch"},{"key":"2026010701521256000_12.1.e003691.10","doi-asserted-by":"publisher","DOI":"10.3201\/eid2206.151642"},{"key":"2026010701521256000_12.1.e003691.11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"key":"2026010701521256000_12.1.e003691.12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0025-6196(25)09678-8","article-title":"Microscopic and baceriologic analysis of expectorated sputum","volume":"50","author":"Murray","year":"1975","journal-title":"Mayo Clin Proc"},{"key":"2026010701521256000_12.1.e003691.13","unstructured":"Eustat . Instituto vasco de estadistica. censo de poblaci\u00f3n y viviendas. Estructura de La Poblaci\u00f3n; 2024."},{"key":"2026010701521256000_12.1.e003691.14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.arbres.2022.11.014","article-title":"Trends of COPD in Spain: Changes Between Cross Sectional Surveys 1997, 2007 and 2017","volume":"59","author":"Garc\u00eda Castillo","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"2026010701521256000_12.1.e003691.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2012.12.011"},{"key":"2026010701521256000_12.1.e003691.16","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.110957"},{"key":"2026010701521256000_12.1.e003691.17","doi-asserted-by":"crossref","DOI":"10.1038\/s41533-024-00403-9","article-title":"A practical guide to the diagnosis and management of suspected Non-tuberculous Mycobacterial Pulmonary Disease (NTM-PD) in the United Kingdom","volume":"34","author":"Dhasmana","year":"2024","journal-title":"NPJ Prim Care Respir Med"},{"key":"2026010701521256000_12.1.e003691.18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.arbres.2023.07.021","article-title":"Clinical and Treatment Outcome Differences Between the Most Common Nontuberculous Mycobacteria (NTM) in the Basque Country","volume":"59","author":"Tabernero Huguet","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"2026010701521256000_12.1.e003691.19","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-1355"},{"key":"2026010701521256000_12.1.e003691.20","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000501697","article-title":"Identification of Non-Tuberculous Mycobacteria in COPD Patients Undergoing Lung Volume Reduction: More Frequent than Expected?","volume":"98","author":"Berra","year":"2019","journal-title":"Respiration"},{"key":"2026010701521256000_12.1.e003691.21","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-14-124","article-title":"Evidence of mycobacterial disease in COPD patients with lung volume reduction surgery; the importance of histological assessment of specimens: a cohort study","volume":"14","author":"Char","year":"2014","journal-title":"BMC Pulm Med"},{"key":"2026010701521256000_12.1.e003691.22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.37201\/req\/121.2020","article-title":"Patients with non-tuberculous mycobacteria in respiratory samples: a 5-year epidemiological study","volume":"34","author":"Matesanz L\u00f3pez","year":"2021","journal-title":"Rev Esp Quimioter"},{"key":"2026010701521256000_12.1.e003691.23","doi-asserted-by":"crossref","DOI":"10.3390\/jpm14111089","article-title":"Prevalence of Chronic Obstructive Pulmonary Disease in Patients with Nontuberculous Mycobacterial Pulmonary Disease: A Systemic Review and Meta-Analysis","volume":"14","author":"Lee","year":"2024","journal-title":"J Pers Med"},{"key":"2026010701521256000_12.1.e003691.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2023.08.012"},{"key":"2026010701521256000_12.1.e003691.25","doi-asserted-by":"crossref","unstructured":"Shah NM , Davidson JA , Anderson LF , et al . Pulmonary Mycobacterium avium-intracellulare is the main driver of the rise in non-tuberculous mycobacteria incidence in England, Wales and Northern Ireland, 2007\u20132012. BMC Infect Dis 2016;16. doi:10.1186\/s12879-016-1521-3","DOI":"10.1186\/s12879-016-1521-3"},{"key":"2026010701521256000_12.1.e003691.26","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1164\/rccm.202210-1949LE","article-title":"Clinicians\u2019 and Researchers\u2019 Perspectives on a New Chronic Obstructive Pulmonary Disease Exacerbation Definition: Rome Wasn\u2019t Built in a Day","volume":"207","author":"Althobiani","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026010701521256000_12.1.e003691.27","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/218253","article-title":"Patients with MAC Lung Disease Have a Low Visceral Fat Area and Low Nutrient Intake","volume":"2015","author":"Wakamatsu","year":"2015","journal-title":"Pulm Med"},{"key":"2026010701521256000_12.1.e003691.28","first-page":"927","article-title":"Identifying potentially undiagnosed nontuberculous mycobacterial lung disease among patients with chronic obstructive pulmonary disease: Development of a predictive algorithm using claims data","volume":"29","author":"Wang","year":"2023","journal-title":"J Manag Care Spec Pharm"},{"key":"2026010701521256000_12.1.e003691.29","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201709-727OC"},{"key":"2026010701521256000_12.1.e003691.30","doi-asserted-by":"publisher","DOI":"10.1159\/000231975"},{"key":"2026010701521256000_12.1.e003691.31","first-page":"247","article-title":"Neutrophil Modulation in Alpha-1 Antitrypsin Deficiency","volume":"7","author":"Sapey","year":"2020","journal-title":"Chronic Obstr Pulm Dis"},{"key":"2026010701521256000_12.1.e003691.32","doi-asserted-by":"publisher","DOI":"10.1080\/00365540701225744"},{"key":"2026010701521256000_12.1.e003691.33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.resinv.2018.11.004","article-title":"Development of lung cancer in patients with nontuberculous mycobacterial lung disease","volume":"57","author":"Kusumoto","year":"2019","journal-title":"Respir Investig"},{"key":"2026010701521256000_12.1.e003691.34","doi-asserted-by":"crossref","first-page":"5619","DOI":"10.3390\/jcm11195619","article-title":"Non-Tuberculous Mycobacteria and Aspergillus Lung Co-Infection: Systematic Review","volume":"11","author":"Fayos","year":"2022","journal-title":"JCM"},{"key":"2026010701521256000_12.1.e003691.35","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2014-206470"},{"key":"2026010701521256000_12.1.e003691.36","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2019.12.907","article-title":"Long-term impact of inhaled corticosteroid use in asthma and chronic obstructive pulmonary disease (COPD): Review of mechanisms that underlie risks","volume":"146","author":"Singanayagam","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"2026010701521256000_12.1.e003691.37","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00737-2022","article-title":"Global survey of physician testing practices for nontuberculous mycobacteria","volume":"9","author":"Loebinger","year":"2023","journal-title":"ERJ Open Res"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-003691","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T09:53:59Z","timestamp":1767779639000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-003691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,21]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjresp-2025-003691"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-003691","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]}}}